Glenmark Recalls Aprepitant Capsules Due to Missing Capsules in Blister Packs
Glenmark Pharmaceuticals is recalling 5,016 blister packs of Aprepitant 40 mg capsules because some packs are missing capsules.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The issue is a packaging defect (missing capsules) rather than a contamination or labeling error affecting safety.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling 5,016 blister packs of Aprepitant Capsules, USP 40 mg. The recall is due to customer reports that some blister packs are missing capsules.
The affected product is Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only. The specific lot number is 17180918 with an expiration date of June 2020. The product was distributed nationwide.
Consumers should check their blister packs for missing capsules. If a capsule is missing, they should contact their healthcare provider or pharmacist for guidance.
The recalled product
- Product
- APREPITANT (APREPITANT)
- Brand
- APREPITANT
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 5,016
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: 17180918
- EXP June 2020
UPCs (5)
- 0368462585764
- 0368462112335
- 0368462584767
- 0368462583401
- 368462583401
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · APREPITANT
- ModerateAprepitant 40 mg Prescription Drug Recalled for Manufacturing Temperature Deviations
FDA (Drugs) · 2022-06-15
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12